Dr. Nadine M. Saad

Dr. Turnier is a physician scientist and Clinical Lecturer in Pediatric Rheumatology at the University of Michigan. She received her MD degree from the University of Cincinnati College of Medicine in 2011. She completed her residency in Pediatrics at the University of Colorado, Children’s Hospital Colorado in 2014. She returned to the University of Cincinnati, Cincinnati Children’s Hospital and completed her Pediatric Rheumatology fellowship and training in clinical and translational research in 2017. Dr. Turnier joined the University of Michigan faculty in 2018. She cares for all children with rheumatologic diseases. Her research focuses on improving clinical care for children with myositis and lupus. Dr. Turnier is studying skin disease in myositis and lupus to identify novel disease mechanisms, biomarkers and treatment targets. She uses bioinformatic and translational science approaches to understand how we can develop precision medicine for myositis and lupus patient care and treatment. Dr. Turnier is also developing a multidisciplinary juvenile myositis clinic to increase access to state of the art clinical care and better integrate research with clinical care. Dr. Turnier is highly rated in 3 conditions, according to our data. Her top areas of expertise are Juvenile Dermatomyositis, Dermatomyositis, Systemic Lupus Erythematosus (SLE), and Juvenile Idiopathic Arthritis (JIA).

Kelly Walkovich is a Pediatrics provider in Ann Arbor, Michigan. Dr. Walkovich is highly rated in 31 conditions, according to our data. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Infantile Neutropenia, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Dr. Steven Pipe is a Professor and the Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology at the University of Michigan, Ann Arbor, Michigan, USA. He is the medical director of the Pediatric Hemophilia and Coagulation Disorders Program and medical director of the Special Coagulation Laboratory. His clinical interests include bleeding and thrombotic disorders and congenital vascular anomalies. Dr Pipe also directs a basic research lab investigating coagulation factor VIII and the molecular mechanisms of hemophilia A. He has been actively involved in clinical trials with novel therapeutics for hemophilia including gene therapy. He was the 2015 recipient of the Leadership in Research Award from the National Hemophilia Foundation. He has served on the Board of Directors for the Hemostasis and Thrombosis Research Society, as Chair of the Board of Directors for the American Thrombosis and Hemostasis Network and currently as Chair of the Medical and Scientific Advisory Committee to the National Hemophilia Foundation. Dr. Pipe is highly rated in 5 conditions, according to our data. His top areas of expertise are Hemophilia A, Hemophilia B, Blood Clots, and Von Willebrand Disease (VWD).